You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Is MYCN Overexpression Associated With Poor Outcome in MYCN Non-Amplified Neuroblastomas?

Pediatric and Developmental Pathology

Impact Factor: 1.3 / 5-Year Impact Factor: 1.3

Journal Homepage Submission guidelines

Restricted access

Letter

First published online May, 2024

Is MYCN Overexpression Associated With Poor Outcome in MYCN Non-Amplified Neuroblastomas?

and

Volume 27, Issue 3

https://doi.org/10.1177/10935266231222321

Abstract

Get full access to this article

View all access options for this article.

References

1.

Zhao

M

Gu

W

Liu

F

, et al. Prominent staining of MYCN immunohistochemistry predicts a poor prognosis in MYCN non-amplified neuroblastoma. Pediatr Dev Pathol. 2023;26(2):124-132.

2.

Yang

Y

Zhao

J

Zhang

Y

, et al. MYCN protein stability is a better prognostic indicator in neuroblastoma. BMC Pediatr. 2022;22(1):404.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

A Parallel-Group Comparison of Budesonide and Beclomethasone Dipropionate for the Treatment of Perennial Allergic Rhinitis in Adults

Retricted access

A Double-Blind Study Comparing Oleum Horwathiensis with Placebo in the Treatment of Psoriasis

Retricted access

Pleura Nodosum: Fetal Squamous Debris in an Unusual Location

Retricted access

PAX3 is Expressed in the Stromal Compartment of the Developing Kidney and in Wilms Tumors with Myogenic Phenotype